Mark J Peters1,2, Gareth A L Jones3,4, Daisy Wiley5, Jerome Wulff5, Padmanabhan Ramnarayan6,7, Samiran Ray4, David Inwald7, Michael Grocott8, Michael Griksaitis9,10, John Pappachan9,10, Lauran O'Neill4, Simon Eaton11, Paul R Mouncey5, David A Harrison5, Kathryn M Rowan5. 1. Respiratory Critical Care and Anaesthesia Unit, UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH, UK. mark.peters@ucl.ac.uk. 2. Paediatric Intensive Care Unit, Great Ormond Street Hospital, London, UK. mark.peters@ucl.ac.uk. 3. Respiratory Critical Care and Anaesthesia Unit, UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH, UK. 4. Paediatric Intensive Care Unit, Great Ormond Street Hospital, London, UK. 5. Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), Napier House, High Holborn, London, UK. 6. Children's Acute Transport Service, Great Ormond Street Hospital, London, UK. 7. Paediatric Intensive Care Unit, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK. 8. Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. 9. Paediatric Intensive Care Unit, Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK. 10. The NIHR Biomedical Biomedical Research Centre, Southampton, UK. 11. Stem Cells and Regenerative Medicine Section, UCL Great Ormond Street Institute of Child Health, London, UK.
Abstract
BACKGROUND:Oxygen saturation monitoring for children receiving respiratory support is standard worldwide. No randomised clinical trials have compared peripheral oxygen saturation (SpO2) targets for critically ill children. The harm of interventions to raise SpO2 to > 94% may exceed their benefits. METHODS: We undertook an open, parallel-group randomised trial of children > 38 weeks completed gestation and < 16 years of age receiving invasive or non-invasive respiratory support and supplemental oxygen who were admitted urgently to one of three paediatric intensive care units. A 'research without prior consent' approach was employed. Children were randomly assigned to a liberal oxygenation group (SpO2 targets > 94%) or a conservative oxygenation group (SpO2 = 88-92% inclusive). Outcomes were measures of feasibility: recruitment rate, protocol adherence and acceptability, between-group separation of SpO2 and safety. The Oxy-PICU trial was registered before recruitment: ClinicalTrials.gov identifier NCT03040570. RESULTS: A total of 159 children met the inclusion criteria, of whom 119 (75%) were randomised between April and July 2017, representing a rate of 10 patients per month per site. The mean time to randomisation from first contact with an intensive care team was 1.9 (SD 2.2) h. Consent to continue in the study was obtained in 107 cases (90%); the children's parents/legal representatives were supportive of the consent process. The median (interquartile range, IQR) of time-weighted individual mean SpO2 was 94.9% (92.6-97.1) in the conservative oxygenation group and 97.5% (96.2-98.4) in the liberal group [difference 2.7%, 95% confidence interval (95% CI) 1.3-4.0%, p < 0.001]. Median (IQR) time-weighted individual meanFiO2 was 0.28 (0.24-0.37) in the conservative group and 0.37 (0.30-0.42) in the liberal group (difference 0.08, 95% CI 0.03-0.13, p < 0.001). There were no significant between-group differences in length of stay, duration of organ support or mortality. Two prespecified serious adverse events (cardiac arrests) occurred, both in the liberal oxygenation group. CONCLUSION: A definitive clinical trial of peripheral oxygen saturation targets is feasible in critically ill children.
RCT Entities:
BACKGROUND:Oxygen saturation monitoring for children receiving respiratory support is standard worldwide. No randomised clinical trials have compared peripheral oxygen saturation (SpO2) targets for critically ill children. The harm of interventions to raise SpO2 to > 94% may exceed their benefits. METHODS: We undertook an open, parallel-group randomised trial of children > 38 weeks completed gestation and < 16 years of age receiving invasive or non-invasive respiratory support and supplemental oxygen who were admitted urgently to one of three paediatric intensive care units. A 'research without prior consent' approach was employed. Children were randomly assigned to a liberal oxygenation group (SpO2 targets > 94%) or a conservative oxygenation group (SpO2 = 88-92% inclusive). Outcomes were measures of feasibility: recruitment rate, protocol adherence and acceptability, between-group separation of SpO2 and safety. The Oxy-PICU trial was registered before recruitment: ClinicalTrials.gov identifier NCT03040570. RESULTS: A total of 159 children met the inclusion criteria, of whom 119 (75%) were randomised between April and July 2017, representing a rate of 10 patients per month per site. The mean time to randomisation from first contact with an intensive care team was 1.9 (SD 2.2) h. Consent to continue in the study was obtained in 107 cases (90%); the children's parents/legal representatives were supportive of the consent process. The median (interquartile range, IQR) of time-weighted individual mean SpO2 was 94.9% (92.6-97.1) in the conservative oxygenation group and 97.5% (96.2-98.4) in the liberal group [difference 2.7%, 95% confidence interval (95% CI) 1.3-4.0%, p < 0.001]. Median (IQR) time-weighted individual mean FiO2 was 0.28 (0.24-0.37) in the conservative group and 0.37 (0.30-0.42) in the liberal group (difference 0.08, 95% CI 0.03-0.13, p < 0.001). There were no significant between-group differences in length of stay, duration of organ support or mortality. Two prespecified serious adverse events (cardiac arrests) occurred, both in the liberal oxygenation group. CONCLUSION: A definitive clinical trial of peripheral oxygen saturation targets is feasible in critically ill children.
Authors: Ardavan Khoshnood; Marcus Carlsson; Mahin Akbarzadeh; Pallonji Bhiladvala; Anders Roijer; Stefan Bodetoft; Peter Höglund; David Zughaft; Lizbet Todorova; David Erlinge; Ulf Ekelund Journal: Cardiology Date: 2015-05-20 Impact factor: 1.869
Authors: J Hope Kilgannon; Alan E Jones; Joseph E Parrillo; R Phillip Dellinger; Barry Milcarek; Krystal Hunter; Nathan I Shapiro; Stephen Trzeciak Journal: Circulation Date: 2011-05-23 Impact factor: 29.690
Authors: Jonathan Elmer; Michael Scutella; Raghevesh Pullalarevu; Bo Wang; Nishit Vaghasia; Stephen Trzeciak; Bedda L Rosario-Rivera; Francis X Guyette; Jon C Rittenberger; Cameron Dezfulian Journal: Intensive Care Med Date: 2014-12-04 Impact factor: 17.440
Authors: Nathaniel R Sznycer-Taub; Ray Lowery; Sunkyung Yu; Sonal T Owens; Jennifer C Hirsch-Romano; Gabe E Owens Journal: Pediatr Crit Care Med Date: 2016-04 Impact factor: 3.624
Authors: Waldemar A Carlo; Neil N Finer; Michele C Walsh; Wade Rich; Marie G Gantz; Abbot R Laptook; Bradley A Yoder; Roger G Faix; Abhik Das; W Kenneth Poole; Kurt Schibler; Nancy S Newman; Namasivayam Ambalavanan; Ivan D Frantz; Anthony J Piazza; Pablo J Sánchez; Brenda H Morris; Nirupama Laroia; Dale L Phelps; Brenda B Poindexter; C Michael Cotten; Krisa P Van Meurs; Shahnaz Duara; Vivek Narendran; Beena G Sood; T Michael O'Shea; Edward F Bell; Richard A Ehrenkranz; Kristi L Watterberg; Rosemary D Higgins Journal: N Engl J Med Date: 2010-05-16 Impact factor: 91.245
Authors: Hendrik J F Helmerhorst; Marcus J Schultz; Peter H J van der Voort; Evert de Jonge; David J van Westerloo Journal: Crit Care Date: 2015-08-17 Impact factor: 9.097
Authors: Daniel S Martin; Margaret McNeil; Chris Brew-Graves; Helder Filipe; Ronan O'Driscoll; Jia Liu Stevens; Rachel Burnish; Andrew F Cumpstey; Norman R Williams; Michael G Mythen; Michael Pw Grocott Journal: J Intensive Care Soc Date: 2021-04-08
Authors: Mark J Peters; Kerry Woolfall; Imran Khan; Elisabeth Deja; Paul R Mouncey; Jerome Wulff; Alexina Mason; Rachel S Agbeko; Elizabeth S Draper; Blaise Fenn; Doug W Gould; Abby Koelewyn; Nigel Klein; Christine Mackerness; Sian Martin; Lauran O'Neill; Samiran Ray; Padmanabhan Ramnarayan; Shane Tibby; Kentigern Thorburn; Lyvonne Tume; Jason Watkins; Paul Wellman; David A Harrison; Kathryn M Rowan Journal: Crit Care Date: 2019-03-07 Impact factor: 9.097
Authors: Sriram Ramgopal; Cameron Dezfulian; Robert W Hickey; Alicia K Au; Shekhar Venkataraman; Robert S B Clark; Christopher M Horvat Journal: JAMA Netw Open Date: 2019-08-02
Authors: Alvin Richards-Belle; Peter Davis; Laura Drikite; Richard Feltbower; Richard Grieve; David A Harrison; Julie Lester; Kevin P Morris; Paul R Mouncey; Mark J Peters; Kathryn M Rowan; Zia Sadique; Lyvonne N Tume; Padmanabhan Ramnarayan Journal: BMJ Open Date: 2020-08-04 Impact factor: 2.692